Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01326767
What this trial is testing

Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Central European Society for Anticancer Drug Research 366
Early research (Phase 1)Study completedNCT01423305
What this trial is testing

Phase I Pharmacokinetic Study (BF-BLOCK)

Who this might be right for
Asthma
Orion Corporation, Orion Pharma 20
Testing effectiveness (Phase 2)Study completedNCT02514447
What this trial is testing

Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy

Who this might be right for
Small Cell Lung Cancer
G1 Therapeutics, Inc. 123
Early research (Phase 1)UnknownNCT05912049
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Mabwell (Shanghai) Bioscience Co., Ltd. 24
Early research (Phase 1)Study completedNCT03238482
What this trial is testing

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

Who this might be right for
Asthma
Orion Corporation, Orion Pharma 64
Early research (Phase 1)Active Not RecruitingNCT04603287
What this trial is testing

SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07285148
What this trial is testing

Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerEGFR MutationMetastatic Lung Cancer+1 more
Beijing Pearl Biotechnology Limited Liability Company 253
Large-scale testing (Phase 3)Study completedNCT02172326
What this trial is testing

Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 29
Early research (Phase 1)Study completedNCT04095286
What this trial is testing

Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07063329
What this trial is testing

Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Avistone Pharmaceutical（Ningbo）Co., LTD. 108
Early research (Phase 1)Study completedNCT03981094
What this trial is testing

The Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Bristol-Myers Squibb 22
Early research (Phase 1)Study completedNCT01563042
What this trial is testing

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

Who this might be right for
Asthma
GlaxoSmithKline 5
Testing effectiveness (Phase 2)Looking for participantsNCT06747923
What this trial is testing

SB17170 Phase 2 Trial in IPF Patients

Who this might be right for
IPFIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
SPARK Biopharma 30
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Early research (Phase 1)Study completedNCT02029313
What this trial is testing

Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma

Who this might be right for
Asthma and Allergic Rhinitis
PharmaKing 40
Early research (Phase 1)Study completedNCT02403713
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers

Who this might be right for
Asthma
Mundipharma Research Limited 125
Early research (Phase 1)Study completedNCT02459158
What this trial is testing

Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia

Who this might be right for
Pneumonia, Bacterial
Meiji Seika Pharma Co., Ltd. 25
Early research (Phase 1)Study completedNCT00411814
What this trial is testing

GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

Who this might be right for
Asthma
GlaxoSmithKline 56
Early research (Phase 1)Study completedNCT02162485
What this trial is testing

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

Who this might be right for
Asthma
Orion Corporation, Orion Pharma 129
Early research (Phase 1)Study completedNCT04720443
What this trial is testing

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
The National Institutes of Pharmaceutical R&D Co. Ltd, China 56
Next Page